[96a5a0]: / output / allTrials / identified / NCT00169520_identified.json

Download this file

358 lines (358 with data), 14.8 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
{
"info": {
"nct_id": "NCT00169520",
"official_title": "A Phase I, Open-Label Study of SB-715992 in Combination With Docetaxel in Patients With Advanced Solid Tumors.",
"inclusion_criteria": "Healthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": "Inclusion criteria:\n\n* Histologically or cytologically confirmed diagnosis of an advanced solid tumor malignancy that is not responsive to standard therapies or for which there is no standard therapy.\n* ECOG (Eastern Cooperative Oncology Group) Performance Status of 0-2.\n\nExclusion criteria:\n\n* Females who are pregnant or nursing.\n* Pre-existing hemolytic anemia.\n* Pre-existing peripheral neuropathy greater than or equal grade 2. Greater than or equal to 4 prior chemotherapy regimens including neoadjuvant/adjuvant chemotherapy, except breast cancer subjects who may have received more than 4 prior chemotherapy regimens.\n* Absolute neutrophil count less than 1,500/mm3.\n* Platelets less than 100,000/mm3.\n* Hemoglobin less than 9 g/dL.\n* Total bilirubin greater than1.5 mg/dL.\n* AST/ALT greater than 2.5 X upper limit of normal.\n* Creatinine clearance less than or equal to 60 mL/min (calculated by the Cockcroft Gault Formula).\n* Known contraindications to the use of docetaxel or to other drugs formulated with polysorbate 80."
},
"inclusion_lines": [
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [
{
"line": "* Histologically or cytologically confirmed diagnosis of an advanced solid tumor malignancy that is not responsive to standard therapies or for which there is no standard therapy.",
"criterions": [
{
"exact_snippets": "Histologically or cytologically confirmed diagnosis",
"criterion": "diagnosis confirmation method",
"requirements": [
{
"requirement_type": "method",
"expected_value": [
"histologically",
"cytologically"
]
}
]
},
{
"exact_snippets": "advanced solid tumor malignancy",
"criterion": "tumor type",
"requirements": [
{
"requirement_type": "type",
"expected_value": "advanced solid tumor malignancy"
}
]
},
{
"exact_snippets": "not responsive to standard therapies",
"criterion": "response to standard therapies",
"requirements": [
{
"requirement_type": "response",
"expected_value": false
}
]
},
{
"exact_snippets": "for which there is no standard therapy",
"criterion": "availability of standard therapy",
"requirements": [
{
"requirement_type": "availability",
"expected_value": false
}
]
}
]
},
{
"line": "* ECOG (Eastern Cooperative Oncology Group) Performance Status of 0-2.",
"criterions": [
{
"exact_snippets": "ECOG (Eastern Cooperative Oncology Group) Performance Status of 0-2",
"criterion": "ECOG Performance Status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Females who are pregnant or nursing.",
"criterions": [
{
"exact_snippets": "Females who are pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Females who are ... nursing",
"criterion": "nursing",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Pre-existing hemolytic anemia.",
"criterions": [
{
"exact_snippets": "Pre-existing hemolytic anemia",
"criterion": "hemolytic anemia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Pre-existing peripheral neuropathy greater than or equal grade 2. Greater than or equal to 4 prior chemotherapy regimens including neoadjuvant/adjuvant chemotherapy, except breast cancer subjects who may have received more than 4 prior chemotherapy regimens.",
"criterions": [
{
"exact_snippets": "Pre-existing peripheral neuropathy greater than or equal grade 2.",
"criterion": "peripheral neuropathy",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "grade"
}
}
]
},
{
"exact_snippets": "Greater than or equal to 4 prior chemotherapy regimens",
"criterion": "prior chemotherapy regimens",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "regimens"
}
}
]
},
{
"exact_snippets": "breast cancer subjects who may have received more than 4 prior chemotherapy regimens.",
"criterion": "breast cancer prior chemotherapy regimens",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": "more than 4 regimens"
}
]
}
]
},
{
"line": "* Absolute neutrophil count less than 1,500/mm3.",
"criterions": [
{
"exact_snippets": "Absolute neutrophil count less than 1,500/mm3.",
"criterion": "absolute neutrophil count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 1500,
"unit": "mm3"
}
}
]
}
]
},
{
"line": "* Platelets less than 100,000/mm3.",
"criterions": [
{
"exact_snippets": "Platelets less than 100,000/mm3",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 100000,
"unit": "mm3"
}
}
]
}
]
},
{
"line": "* Hemoglobin less than 9 g/dL.",
"criterions": [
{
"exact_snippets": "Hemoglobin less than 9 g/dL",
"criterion": "hemoglobin",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 9,
"unit": "g/dL"
}
}
]
}
]
},
{
"line": "* Total bilirubin greater than1.5 mg/dL.",
"criterions": [
{
"exact_snippets": "Total bilirubin greater than1.5 mg/dL.",
"criterion": "total bilirubin",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">",
"value": 1.5,
"unit": "mg/dL"
}
}
]
}
]
},
{
"line": "* AST/ALT greater than 2.5 X upper limit of normal.",
"criterions": [
{
"exact_snippets": "AST/ALT greater than 2.5 X upper limit of normal.",
"criterion": "AST/ALT",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">",
"value": 2.5,
"unit": "X upper limit of normal"
}
}
]
}
]
},
{
"line": "* Creatinine clearance less than or equal to 60 mL/min (calculated by the Cockcroft Gault Formula).",
"criterions": [
{
"exact_snippets": "Creatinine clearance less than or equal to 60 mL/min",
"criterion": "creatinine clearance",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<=",
"value": 60,
"unit": "mL/min"
}
}
]
}
]
},
{
"line": "* Known contraindications to the use of docetaxel or to other drugs formulated with polysorbate 80.",
"criterions": [
{
"exact_snippets": "Known contraindications to the use of docetaxel",
"criterion": "contraindications to docetaxel",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "contraindications ... to other drugs formulated with polysorbate 80",
"criterion": "contraindications to drugs formulated with polysorbate 80",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": [
{
"line": "Inclusion criteria:",
"criterions": []
},
{
"line": "Exclusion criteria:",
"criterions": []
}
]
}